Epilepsy in Children and Adolescents 2012
DOI: 10.1002/9781119998600.ch10
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Efficacy of Antiepileptic Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 34 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…Chronic epilepsy affects nearly 500 000 children in the United States, and 30% will become drug resistant-a serious epilepsy-related complication and a significant public health burden-related to inadequate or failed seizure control from 2 or more conventionally dosed AEDs. [5][6][7][8][9][10] Drug resistance presents more than an epilepsy management challenge; it is among the leading risk factors for SE and SUDEP. [11][12][13][14] The danger of drug resistance and other SUDEP risk factors is often inadequately addressed in the literature.…”
Section: Drug Resistance In Epilepsymentioning
confidence: 99%
“…Chronic epilepsy affects nearly 500 000 children in the United States, and 30% will become drug resistant-a serious epilepsy-related complication and a significant public health burden-related to inadequate or failed seizure control from 2 or more conventionally dosed AEDs. [5][6][7][8][9][10] Drug resistance presents more than an epilepsy management challenge; it is among the leading risk factors for SE and SUDEP. [11][12][13][14] The danger of drug resistance and other SUDEP risk factors is often inadequately addressed in the literature.…”
Section: Drug Resistance In Epilepsymentioning
confidence: 99%